10:00 a.m.

Opening Remarks and Day 1 Recap

Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

NIH Leadership Remarks

10:10 a.m.

National Cancer Institute

Lori Minasian, M.D., FACP
Deputy Director, Division of Cancer Prevention
National Cancer Institute
National Institutes of Health

10:15 a.m.

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Rohan Hazra, M.D.
Acting Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health

Key Question 1b:

Do the effectiveness, comparative effectiveness, and harms of treatment vary by timing and type of menopause (early, average, iatrogenic, natural)?

10:20 a.m.

Management of Surgical-Related Early and Premature Menopausal Symptoms—Barbara Norquist, M.D.

10:40 a.m.

Iatrogenic Menopause due to Cancer Treatment: Gaps and Future Directions—Ann Partridge, M.D., M.P.H.

11.00 a.m.

Genitourinary Syndrome of Menopause: Treatment Benefits, Risks, and Potential Impact of Menopause Type and Timing—Jan Shifren, M.D.

11:20 a.m.

Photobiomodulation Therapy of Vaginal Tissue: Genitourinary Syndrome of Menopause—Raymond Lanzafame, M.D., M.B.A., FACS

11:40 a.m.

Discussion

Moderated by
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

12:00 p.m.

Break

Key Question 1c:

Do the effectiveness, comparative effectiveness, and harms of treatment vary by individual- or system-level factors?

12:10 p.m.

Hormones and Alternatives for Women in Menopause Transition at Elevated Risk for Breast Cancer—Carol Fabian, M.D.

12:30 p.m.

Should Menopause Hormone Therapy (MHT) Be Used to Reduce the Long-Term Risk of Cognitive Decline and Dementia?—Walter Rocca, M.D., M.P.H.

12:50 p.m.

Musculoskeletal Health During the Menopause Transition—Fabrisia Ambrosio, Ph.D.

1:10 p.m.

Prevention of Cardiovascular Disease Risks to Ensure Overall Heart Health During the Menopause Transition—Samar El Khoudary, Ph.D., M.P.H., FAHA

 1:30 p.m.

Discussion

Moderated by
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

1:50 p.m.

Lunch Break

General Session 2

Healthy Aging in Women—Supporting Overall Well-Being During the Menopause Transition—Part 2

2:20 p.m.

Moderator Perspectives—Karen Giblin

2:30 p.m.

Perimenopausal-Related Sleep Disturbances: Implications for Neurocognitive and Cardiometabolic Health—Hadine Joffe, M.D., M.Sc.

2:45 p.m.

Menopause, Its Implications for Women’s Heart and Brain Health, and the Role of Trauma—Rebecca Thurston, Ph.D.

3:00 p.m.

Managing Mood and Anxiety in Midlife Women—Claudio Soares, M.D., Ph.D.

3:15 p.m.

Development and Use of Technology to Improve Monitoring and Management of Menopausal Symptoms—Fiona Baker, Ph.D.

3:30 p.m.

Discussion

Moderated by
Karen Giblin

3:50 p.m.

Break

Key Question 2:

What is the impact of individual- or system-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms?

• Individual-level factors include, but are not limited to, educational attainment, patient engagement in health care, lifestyle factors, and comorbidities.
• System-level factors include, but are not limited to, provider bias, access to care, and social determinants of health.

4:00 p.m.

Meera Viswanathan, Ph.D., M.A., B.A.
RTI International–University of North Carolina Evidence-based Practice Center (RTI-UNC EPC) Presentation II

4:20 p.m.

Discussion

Moderated by
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair

4:30 p.m.

Adjourn